Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The launch of a new endoscopy service at the Oxford Experimental Medicine Clinical Research Facility (EMCRF) will enhance the collection of data for research projects at the Nuffield Department of Orthopaedics, Rheumatology & Musculoskeletal Sciences (NDORMS) and across the University of Oxford.

Endoscopy on course with three professional using the new equipment
L to R: Dr Julia Pakpoor, Daria Nastri and Professor Simon Travis view the first endoscopy procedure at the new facility

The first endoscopies at the Oxford Experimental Medicine Clinical Research Facility EMCRF will be low volume, high intensity procedures to support sample collection for our wet lab studies at the Kennedy Institute. Simon Travis, Professor of Clinical Gastroenterology explained: 'Initially it will focus on flexible sigmoidoscopies examining the left side of the colon to support the Sagittarius Study which is being led by Dr Julia Pakpoor. The study is exploring the predictors of response and non-response to advanced therapies for ulcerative colitis at a cellular and molecular level.'

'This facility will really help with the recruitment of patients for the Sagittarius study and relieve the burden on the NHS,' said Dr Julia Pakpoor, Clinical Research Training Fellow at the Kennedy Institute. 'This integration of research, clinical care, and science will be a huge benefit to our patients.'

The Oxford Experimental Medicine Clinical Research Facility EMCRF is a Clinical Research Facility providing a resource for early phase, experimental research across the Medical Sciences Division at the University of Oxford. Studies have included the COVID-19 human challenge study, Paratyphoid vaccine development; Keyhole Limpet Hemocyanin immune challenge, and early interventional trials for idiopathic pulmonary fibrosis, and Huntington's disease.

Read the full story on the Nuffield Department of Orthopaedics, Rheumatology & Musculoskeletal Sciences (NDORMS) website